🇺🇸 FDA
Patent

US 7981931

Pharmaceutical compositions of short-acting sedative hypnotic agent

granted A61KA61K31/20A61K31/216

Quick answer

US patent 7981931 (Pharmaceutical compositions of short-acting sedative hypnotic agent) held by Theravance, Inc. expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/20, A61K31/216, A61K31/325, A61K9/1075